News & Events
Diplomat Specialty Pharmacy currently stocks Simponi™ (golimumab)
06 May 09
Once Dose – Once a Month
Simponi™ (golimumab) now FDA approved for: Rheumatoid Arthritis (RA) SIMPONI™, in combination with methotrexate, is indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis.
Psoriatic Arthritis (PsA) SIMPONI™, alone or in combination with methotrexate, is indicated for the treatment of adult patients with active psoriatic arthritis.
Ankylosing Spondylitis (AS) SIMPONI™ is indicated for the treatment of adult patients with active ankylosing spondylitis.
For more information call Diplomat toll free at: 866.311.9966
Click here for more information about our Psoriasis and Rheumatology Navigator Patient Care Program
Features- Diplomat initiates and manages the entire insurance prior authorization process
- We assist patients with all insurance issues including Appeals & Denials
- Our dedicated Funding Department seeks out any available Patient Assistance Funds
- We cooordinate Medicare Donut Hole Assistance & Mfg’s co-pay assistance cards
- Provide proactive Rx refills and monthly contact with patient
- Free home delivery
Diplomat Provides Full Coordination with the SimponiOne™ Patient Support Program
Benefits- Reduced physician’s office staff involvement
- Improved drug access
- Increased drug access for patients with high co-payments
- Improved patient adherence
- Improved patient convenience